A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

Clinical trial NCT05355701 · RECRUITING

Trial details

NCT number: NCT05355701
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma Non-Small-Cell Lung Cancer Thyroid Cancer Glioma Advanced Colorectal Cancer (Part 1)

Start date: 2022-07-05
Primary completion: 2028-04-23
Enrollment: 267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.